Physician profile
Bret J Warner
NPI 1487654034
$2,035.31
in general payments reported to CMS, 2019-2025
22 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $229 · 2021: $158 · 2022: $141 · 2023: $243 · 2024: $345 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $877.12 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Supernus Pharmaceuticals, INC. | $329.54 | 2019-2021 | |
| Emd Serono, INC. | $145.99 | 2019-2024 | |
| Allergan, INC. | $136.23 | 2019-2021 | |
| Averitas Pharma INC. | $105.57 | 2024-2025 | Qutenza |
| Livanova USA, INC. | $70.37 | 2021 | |
| Cala Health, INC. | $50.34 | 2025 | Cala Kiq |
| Sunovion Pharmaceuticals INC. | $32.49 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Abbott Laboratories | $27.55 | 2021-2022 | |
| Biogen, INC. | $27.03 | 2025 | Vumerity |
| Argenx US, INC. | $26.65 | 2024 | Vyvgart Hytrulo |
| Genzyme Corporation | $26.60 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.44 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.80 | 2024 | Rexulti |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $18.90 | 2020 | |
| Sk Life Science, INC. | $17.06 | 2021 | |
| Amgen INC. | $16.21 | 2025 | Uplizna |
| Catalyst Pharmaceuticals, INC. | $15.34 | 2023 | Fycompa |
| Teva Pharmaceuticals USA, INC. | $14.66 | 2020 | |
| Lilly USA, LLC | $14.30 | 2024 | Emgality |
| Pfizer INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.